Regulation of protein kinases: Controlling activity through activation segment conformation

Molecular Cell

Volumn 15, Issue 5, 2004, Pages 661-675

  Nolen, Brad ^a   Taylor, Susan ^a   Ghosh, Gourisankar ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; CHECKPOINT KINASE 2; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE 6; DEATH ASSOCIATED PROTEIN KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; FLT3 LIGAND; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE LCK; PROTEIN TYROSINE KINASE; SCATTER FACTOR RECEPTOR; STEM CELL FACTOR; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; VASCULOTROPIN RECEPTOR 2;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME CONFORMATION; ENZYME REGULATION; MOLECULAR MECHANICS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW;

AMINO ACID MOTIFS; ANIMALS; CATALYTIC DOMAIN; COMPUTATIONAL BIOLOGY; HUMANS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 4444353636     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2004.08.024     Document Type: Review

References (103)

1. Adams J.A. Kinetic and catalytic mechanisms of protein kinases. Chem. Rev. 101:2001;2271-2290
2. Adams J.A. Activation loop phosphorylation and catalysis in protein kinases. is there functional evidence for the autoinhibitor model? Biochemistry. 42:2003;601-607
3. Ahmed Z., Smith B.J., Kotani K., Wilden P., Pillay T.S. APS, an adapter protein with a PH and SH2 domain, is a substrate for the insulin receptor kinase. Biochem. J. 341:1999;665-668
4. Bax B., Carter P.S., Lewis C., Guy A.R., Bridges A., Tanner R., Pettman G., Mannix C., Culbert A.A., Brown M.J., et al. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation. Structure (Camb). 9:2001;1143-1152
5. Bayliss R., Sardon T., Vernos I., Conti E. Structural basis of Aurora-A activation by TPX2 at the mitotic spindle. Mol. Cell. 12:2003;851-862
6. Bellon S., Fitzgibbon M.J., Fox T., Hsiao H.M., Wilson K.P. The structure of phosphorylated p38gamma is monomeric and reveals a conserved activation-loop conformation. Struct. Fold. Des. 7:1999;1057-1065
7. Biondi R.M., Komander D., Thomas C.C., Lizcano J.M., Deak M., Alessi D.R., van Aalten D.M.F. High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site. EMBO J. 21:2002;4219-4228
8. Brown N.R., Noble M.E., Endicott J.A., Johnson L.N. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat. Cell Biol. 1:1999;438-443
9. Canagarajah B.J., Khokhlatchev A., Cobb M.H., Goldsmith E.J. Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell. 90:1997;859-869
10. Cheetham G.M., Knegtel R.M., Coll J.T., Renwick S.B., Swenson L., Weber P., Lippke J.A., Austen D.A. Crystal structure of aurora-2, an oncogenic serine/threonine kinase. J. Biol. Chem. 277:2002;42419-42422
11. Chen P., Luo C., Deng Y., Ryan K., Register J., Margosiak S., Tempczyk-Russell A., Nguyen B., Myers P., Lundgren K., et al. The 1.7 A crystal structure of human cell cycle checkpoint kinase Chk1. implications for Chk1 regulation Cell. 100:2000;681-692
12. Chen Z., Gibson T.B., Robinson F., Silvestro L., Pearson G., Xu B., Wright A., Vanderbilt C., Cobb M.H. MAP kinases. Chem. Rev. 101:2001;2449-2476
13. Couture C., Deckert M., Williams S., Russo F.O., Altman A., Mustelin T. Identification of the site in the Syk protein tyrosine kinase that binds the SH2 domain of Lck. J. Biol. Chem. 271:1996;24294-24299
14. Cox S., Taylor S.S. Kinetic analysis of cAMP-dependent protein kinase. mutations at histidine 87 affect peptide binding and pH dependence Biochemistry. 34:1995;16203-16209
15. Dajani R., Fraser E., Roe S.M., Young N., Good V., Dale T.C., Pearl L.H. Crystal structure of glycogen synthase kinase 3 beta. structural basis for phosphate-primed substrate specificity and autoinhibition Cell. 105:2001;721-732
16. Dajani R., Fraser E., Roe S.M., Yeo M., Good V.M., Thompson V., Dale T.C., Pearl L.H. Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex. EMBO J. 22:2003;494-501
17. De Bondt H.L., Rosenblatt J., Jancarik J., Jones H.D., Morgan D.O., Kim S.H. Crystal structure of cyclin-dependent kinase 2. Nature. 363:1993;595-602
18. Favelyukis S., Till J.H., Hubbard S.R., Miller W.T. Structure and autoregulation of the insulin-like growth factor 1 receptor kinase. Nat. Struct. Biol. 8:2001;1058-1063
19. George S., Rochford J.J., Wolfrum C., Gray S.L., Schinner S., Wilson J.C., Soos M.A., Murgatroyd P.R., Williams R.M., Acerini C.L., et al. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science. 304:2004;1325-1328
20. Gibbs C.S., Zoller M.J. Rational scanning mutagenesis of a protein kinase identifies functional regions involved in catalysis and substrate interactions. J. Biol. Chem. 266:1991;8923-8931
21. Goldberg J., Nairn A.C., Kuriyan J. Structural basis for the autoinhibition of calcium/calmodulin-dependent protein kinase I. Cell. 84:1996;875-887
22. Goldsmith E.J., Cobb M.H. Protein kinases. Curr. Opin. Struct. Biol. 4:1994;833-840
23. Griffith J., Black J., Faerman C., Swenson L., Wynn M., Lu F., Lippke J., Saxena K. The structural basis for autoinhibition of FLT3 by the juxtamembrane domain. Mol. Cell. 13:2004;169-178
24. Hamuro Y., Wong L., Shaffer J., Kim J.S., Stranz D.D., Jennings P.A., Woods V.L. Jr., Adams J.A. Phosphorylation driven motions in the COOH-terminal Src kinase, CSK, revealed through enhanced hydrogen-deuterium exchange and mass spectrometry (DXMS). J. Mol. Biol. 323:2002;871-881
25. Heo Y.S., Kim S.K., Seo C.I., Kim Y.K., Sung B.J., Lee H.S., Lee J.I., Park S.Y., Kim J.H., Hwang K.Y., et al. Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125. EMBO J. 23:2004;2185-2195
26. Hoofnagle A.N., Resing K.A., Goldsmith E.J., Ahn N.G. Changes in protein conformational mobility upon activation of extracellular regulated protein kinase-2 as detected by hydrogen exchange. Proc. Natl. Acad. Sci. USA. 98:2001;956-961
27. Hoofnagle A.N., Stoner J.W., Lee T., Eaton S.S., Ahn N.G. Phosphorylation-dependent changes in structure and dynamics in ERK2 detected by SDSL and EPR. Biophys. J. 86:2004;395-403
28. Hu J., Liu J., Ghirlando R., Saltiel A.R., Hubbard S.R. Structural basis for recruitment of the adaptor protein APS to the activated insulin receptor. Mol. Cell. 12:2003;1379-1389
29. Huang X., Begley M., Morgenstern K.A., Gu Y., Rose P., Zhao H., Zhu X. Crystal structure of an inactive Akt2 kinase domain. Structure (Camb). 11:2003;21-30
30. Hubbard S.R. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J. 16:1997;5572-5581
31. Hubbard S.R., Wei L., Ellis L., Hendrickson W.A. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature. 372:1994;746-754
32. Huse M., Kuriyan J. The conformational plasticity of protein kinases. Cell. 109:2002;275-282
33. Huse M., Chen Y.G., Massague J., Kuriyan J. Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12. Cell. 96:1999;425-436
34. Jeffrey P.D., Russo A.A., Polyak K., Gibbs E., Hurwitz J., Massague J., Pavletich N.P. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature. 376:1995;313-320
35. Johnson L.N., Lowe E.D., Noble M.E., Owen D.J. The Eleventh Datta Lecture. The structural basis for substrate recognition and control by protein kinases. FEBS Lett. 430:1998;1-11
36. Johnson L.N., Noble M.E., Owen D.J. Active and inactive protein kinases. structural basis for regulation Cell. 85:1996;149-158
37. Knighton D.R., Zheng J.H., Ten Eyck L.F., Ashford V.A., Xuong N.H., Taylor S.S., Sowadski J.M. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science. 253:1991;407-414
38. Kobe B., Heierhorst J., Feil S.C., Parker M.W., Benian G.M., Weiss K.R., Kemp B.E. Giant protein kinases. domain interactions and structural basis of autoregulation EMBO J. 15:1996;6810-6821
39. Lamers M.B., Antson A.A., Hubbard R.E., Scott R.K., Williams D.H. Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine. J. Mol. Biol. 285:1999;713-725
40. Lei M., Lu W., Meng W., Parrini M.C., Eck M.J., Mayer B.J., Harrison S.C. Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch. Cell. 102:2000;387-397
41. Leon B.C., Tsigelny I., Adams J.A. Electrostatic environment surrounding the activation loop phosphotyrosine in the oncoprotein v-Fps. Biochemistry. 40:2001;10078-10086
42. Lew J. MAP kinases and CDKs. kinetic basis for catalytic activation Biochemistry. 42:2003;849-856
43. Li F., Gangal M., Juliano C., Gorfain E., Taylor S.S., Johnson D.A. Evidence for an internal entropy contribution to phosphoryl transfer. a study of domain closure, backbone flexibility, and the catalytic cycle of cAMP-dependent protein kinase J. Mol. Biol. 315:2002;459-469
44. Lin X., Lee S., Sun G. Functions of the activation loop in Csk protein-tyrosine kinase. J. Biol. Chem. 278:2003;24072-24077
45. Lodowski D.T., Pitcher J.A., Capel W.D., Lefkowitz R.J., Tesmer J.J. Keeping G proteins at bay. a complex between G protein-coupled receptor kinase 2 and Gbetagamma Science. 300:2003;1256-1262
46. Longenecker K.L., Roach P.J., Hurley T.D. Three-dimensional structure of mammalian casein kinase I. molecular basis for phosphate recognition J. Mol. Biol. 257:1996;618-631
47. Lowe E.D., Noble M.E., Skamnaki V.T., Oikonomakos N.G., Owen D.J., Johnson L.N. The crystal structure of a phosphorylase kinase peptide substrate complex. kinase substrate recognition EMBO J. 16:1997;6646-6658
48. Madhusudan, Trafny E.A., Xuong N.H., Adams J.A., Ten Eyck L.F., Taylor S.S., Sowadski J.M. cAMP-dependent protein kinase. crystallographic insights into substrate recognition and phosphotransfer Protein Sci. 3:1994;176-187
49. Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S. The protein kinase complement of the human genome. Science. 298:2002;1912-1934
50. Mao C., Zhou M., Uckun F.M. Crystal structure of Bruton's tyrosine kinase domain suggests a novel pathway for activation and provides insights into the molecular basis of X-linked agammaglobulinemia. J. Biol. Chem. 276:2001;41435-41443
51. Mayans O., van der Ven P.F., Wilm M., Mues A., Young P., Furst D.O., Wilmanns M., Gautel M. Structural basis for activation of the titin kinase domain during myofibrillogenesis. Nature. 395:1998;863-869
52. McTigue M.A., Wickersham J.A., Pinko C., Showalter R.E., Parast C.V., Tempczyk-Russell A., Gehring M.R., Mroczkowski B., Kan C.C., Villafranca J.E., et al. Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2. a key enzyme in angiogenesis Struct. Fold. Des. 7:1999;319-330
53. Meng W., Swenson L.L., Fitzgibbon M.J., Hayakawa K., Ter Haar E., Behrens A.E., Fulghum J.R., Lippke J.A. Structure of mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 suggests a bifunctional switch that couples kinase activation with nuclear export. J. Biol. Chem. 277:2002;37401-37405
54. Mohammadi M., Schlessinger J., Hubbard S.R. Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell. 86:1996;577-587
55. Mol C.D., Lim K.B., Sridhar V., Zou H., Chien E.Y., Sang B.C., Nowakowski J., Kassel D.B., Cronin C.N., McRee D.E. Structure of a c-kit product complex reveals the basis for kinase transactivation. J. Biol. Chem. 278:2003;31461-31464
56. Mol C.D., Dougan D.R., Schneider T.R., Skene R.J., Kraus M.L., Scheibe D.N., Snell G.P., Zou H., Sang B.C., Wilson K.P. Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase. J. Biol. Chem. 279:2004;31655-31663
57. Moore M.J., Adams J.A., Taylor S.S. Structural basis for peptide binding in protein kinase A. Role of glutamic acid. 203(and tyrosine 204 in the peptide-positioning loop. J. Biol. Chem. 278):2003;10613-10618
58. Morgan D.O., De Bondt H.L. Protein kinase regulation. insights from crystal structure analysis Curr. Opin. Cell Biol. 6:1994;239-246
59. Munshi S., Hall D.L., Kornienko M., Darke P.L., Kuo L.C. Structure of apo, unactivated insulin-like growth factor-1 receptor kinase at 1.5 A resolution. Acta Crystallogr. D Biol. Crystallogr. 59:2003;1725-1730
60. Nagar B., Hantschel O., Young M.A., Scheffzek K., Veach D., Bornmann W., Clarkson B., Superti-Furga G., Kuriyan J. Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell. 112:2003;859-871
61. Niefind K., Guerra B., Pinna L.A., Issinger O.G., Schomburg D. Crystal structure of the catalytic subunit of protein kinase CK2 from Zea mays at 2.1 A resolution. EMBO J. 17:1998;2451-2462
62. Niefind K., Putter M., Guerra B., Issinger O.G., Schomburg D. GTP plus water mimic ATP in the active site of protein kinase CK2. Nat. Struct. Biol. 6:1999;1100-1103
63. Nolen B., Yun C.Y., Wong C.F., McCammon J.A., Fu X.D., Ghosh G. The structure of Sky1p reveals a novel mechanism for constitutive activity. Nat. Struct. Biol. 8:2001;176-183
64. Nolen B., Ngo J., Chakrabarti S., Vu D., Adams J.A., Ghosh G. Nucleotide-induced conformational changes in the Saccharomyces cerevisiae SR protein kinase, Sky1p, revealed by X-ray crystallography. Biochemistry. 42:2003;9575-9585
65. Nowakowski J., Cronin C.N., McRee D.E., Knuth M.W., Nelson C.G., Pavletich N.P., Rogers J., Sang B.C., Scheibe D.N., Swanson R.V., et al. Structures of the cancer-related Aurora-A, FAK, and EphA2 protein kinases from nanovolume crystallography. Structure (Camb). 10:2002;1659-1667
66. Ogawa A., Takayama Y., Sakai H., Chong K.T., Takeuchi S., Nakagawa A., Nada S., Okada M., Tsukihara T. Structure of the carboxyl-terminal Src kinase, Csk. J. Biol. Chem. 277:2002;14351-14354
67. Owen D.J., Noble M.E., Garman E.F., Papageorgiou A.C., Johnson L.N. Two structures of the catalytic domain of phosphorylase kinase. an active protein kinase complexed with substrate analogue and product Structure. 3:1995;467-482
68. Pautsch A., Zoephel A., Ahorn H., Spevak W., Hauptmann R., Nar H. Crystal structure of bisphosphorylated IGF-1 receptor kinase. insight into domain movements upon kinase activation Structure (Camb). 9:2001;955-965
69. Pinna L.A., Ruzzene M. How do protein kinases recognize their substrates? Biochim. Biophys. Acta. 1314:1996;191-225
70. Prowse C.N., Deal M.S., Lew J. The complete pathway for catalytic activation of the mitogen-activated protein kinase, ERK2. J. Biol. Chem. 276:2001;40817-40823
71. Roach P.J. Multisite and hierarchal protein phosphorylation. J. Biol. Chem. 266:1991;14139-14142
72. Russo A.A., Jeffrey P.D., Pavletich N.P. Structural basis of cyclin-dependent kinase activation by phosphorylation. Nat. Struct. Biol. 3:1996;696-700
73. Schiering N., Knapp S., Marconi M., Flocco M.M., Cui J., Perego R., Rusconi L., Cristiani C. Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a. Proc. Natl. Acad. Sci. USA. 100:2003;12654-12659
74. Schulze-Gahmen U., Kim S.H. Structural basis for CDK6 activation by a virus-encoded cyclin. Nat. Struct. Biol. 9:2002;177-181
75. Schulze-Gahmen U., De Bondt H.L., Kim S.H. High-resolution crystal structures of human cyclin-dependent kinase 2 with and without ATP. bound waters and natural ligand as guides for inhibitor design J. Med. Chem. 39:1996;4540-4546
76. Shaffer J., Adams J.A. Detection of conformational changes along the kinetic pathway of protein kinase A using a catalytic trapping technique. Biochemistry. 38:1999;12072-12079
77. Shewchuk L.M., Hassell A.M., Ellis B., Holmes W.D., Davis R., Horne E.L., Kadwell S.H., McKee D.D., Moore J.T. Structure of the Tie2 RTK domain. self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail Struct. Fold. Des. 8:2000;1105-1113
78. Sicheri F., Moarefi I., Kuriyan J. Crystal structure of the Src family tyrosine kinase Hck. Nature. 385:1997;602-609
79. Skamnaki V.T., Owen D.J., Noble M.E., Lowe E.D., Lowe G., Oikonomakos N.G., Johnson L.N. Catalytic mechanism of phosphorylase kinase probed by mutational studies. Biochemistry. 38:1999;14718-14730
80. Sowadski J.M., Epstein L.F., Lankiewicz L., Karlsson R. Conformational diversity of catalytic cores of protein kinases. Pharmacol. Ther. 82:1999;157-164
81. Stamos J., Sliwkowski M.X., Eigenbrot C. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J. Biol. Chem. 277:2002;46265-46272
82. Tarricone C., Dhavan R., Peng J., Areces L.B., Tsai L.H., Musacchio A. Structure and regulation of the CDK5-p25(nck5a) complex. Mol. Cell. 8:2001;657-669
83. Taylor S.S., Radzio-Andzelm E. Three protein kinase structures define a common motif. Structure. 2:1994;345-355
84. ter Haar E., Coll J.T., Austen D.A., Hsiao H.M., Swenson L., Jain J. Structure of GSK3beta reveals a primed phosphorylation mechanism. Nat. Struct. Biol. 8:2001;593-596
85. Tereshko V., Teplova M., Brunzelle J., Watterson D.M., Egli M. Crystal structures of the catalytic domain of human protein kinase associated with apoptosis and tumor suppression. Nat. Struct. Biol. 8:2001;899-907
86. Till J.H., Becerra M., Watty A., Lu Y., Ma Y., Neubert T.A., Burden S.J., Hubbard S.R. Crystal structure of the MuSK tyrosine kinase. insights into receptor autoregulation Structure (Camb). 10:2002;1187-1196
87. Underwood K.W., Parris K.D., Federico E., Mosyak L., Czerwinski R.M., Shane T., Taylor M., Svenson K., Liu Y., Hsiao C.L., et al. Catalytically active MAP KAP kinase 2 structures in complex with staurosporine and ADP reveal differences with the autoinhibited enzyme. Structure (Camb). 11:2003;627-636
88. Wan P.T., Garnett M.J., Roe S.M., Lee S., Niculescu-Duvaz D., Good V.M., Jones C.M., Marshall C.J., Springer C.J., Barford D., et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell. 116:2004;855-867
89. Wang Z., Harkins P.C., Ulevitch R.J., Han J., Cobb M.H., Goldsmith E.J. The structure of mitogen-activated protein kinase p38 at 2.1-A resolution. Proc. Natl. Acad. Sci. USA. 94:1997;2327-2332
90. Wiechmann S., Czajkowska H., de Graaf K., Grotzinger J., Joost H.G., Becker W. Unusual function of the activation loop in the protein kinase DYRK1A. Biochem. Biophys. Res. Commun. 302:2003;403-408
91. Wilson K.P., Fitzgibbon M.J., Caron P.R., Griffith J.P., Chen W., McCaffrey P.G., Chambers S.P., Su M.S. Crystal structure of p38 mitogen-activated protein kinase. J. Biol. Chem. 271:1996;27696-27700
92. Wolf I., Rubinfeld H., Yoon S., Marmor G., Hanoch T., Seger R. Involvement of the activation loop of ERK in the detachment from cytosolic anchoring. J. Biol. Chem. 276:2001;24490-24497
93. Wybenga-Groot L.E., Baskin B., Ong S.H., Tong J., Pawson T., Sicheri F. Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region. Cell. 106:2001;745-757
94. Xie X., Gu Y., Fox T., Coll J.T., Fleming M.A., Markland W., Caron P.R., Wilson K.P., Su M.S. Crystal structure of JNK3. a kinase implicated in neuronal apoptosis Structure. 6:1998;983-991
95. Xu W., Harrison S.C., Eck M.J. Three-dimensional structure of the tyrosine kinase c-Src. Nature. 385:1997;595-602
96. Yamaguchi H., Hendrickson W.A. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation. Nature. 384:1996;484-489
97. Yang J., Cron P., Good V.M., Thompson V., Hemmings B.A., Barford D. Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP. Nat. Struct. Biol. 9:2002;940-944. a
98. Yang J., Cron P., Thompson V., Good V.M., Hess D., Hemmings B.A., Barford D. Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Mol. Cell. 9:2002;1227-1240. b
99. Young T.A., Delagoutte B., Endrizzi J.A., Falick A.M., Alber T. Structure of Mycobacterium tuberculosis PknB supports a universal activation mechanism for Ser/Thr protein kinases. Nat. Struct. Biol. 10:2003;168-174
100. Zhang B.H., Guan K.L. Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601. EMBO J. 19:2000;5429-5439
101. Zhang F., Strand A., Robbins D., Cobb M.H., Goldsmith E.J. Atomic structure of the MAP kinase ERK2 at 2.3 A resolution. Nature. 367:1994;704-711
102. Zheng J., Knighton D.R., ten Eyck L.F., Karlsson R., Xuong N., Taylor S.S., Sowadski J.M. Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor. Biochemistry. 32:1993;2154-2161. a
103. Zheng J., Trafny E.A., Knighton D.K., Xuong N., Taylor S., Ten Eyck L., Sowadski J. 2.2-Angstrom refined crystal structure of the catalytic subunit of cAMP-dependent Protein Kinase complexed with MnATP and a peptide inhibitor. Acta Crystallogr. D Biol. Crystallogr. 49:1993;362-365. b